HealthcareWith a second spike of the virus, markets would be especially sensitive to healthcare news, much like we saw during the first wave. Healthcare companies have already begun to innovate in many ways, with advancements in telemedicine being readily visible, but the major innovation will come as companies get closer to a reliable vaccine. The strongest reason to be bullish on the sector, however, has to do with its stability during difficult periods in the economic cycle. Companies like Johnson & Johnson and Pfizer have been dividend aristocrats for decades, and will continue to persevere through a second wave. Healthcare is not entirely recession-proof, as non-urgent and elective procedures may be postponed, but the core of the industry will continue to exist in a position of strength.

Source: Daily Sun June 28, 2020 12:00 UTC